The paper referenced by the authors (5) to support this claim, in turn, cites a third source that states, “...the IHC detection of p53 protein suggests an underlying mutation in the gene.” These nuances require precise language for a balanced discussion of p53 prognostication in MDS. The gene discussed is TP53; the disease is myelodysplastic syndrome.